Amalgamated Bank Decreases Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Amalgamated Bank reduced its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 14.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 46,803 shares of the company’s stock after selling 7,697 shares during the quarter. Amalgamated Bank owned 0.05% of Acadia Healthcare worth $3,161,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Blue Trust Inc. grew its stake in Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after buying an additional 248 shares during the period. Mather Group LLC. purchased a new position in shares of Acadia Healthcare in the first quarter valued at $48,000. nVerses Capital LLC purchased a new position in shares of Acadia Healthcare in the second quarter valued at $95,000. Innealta Capital LLC purchased a new position in shares of Acadia Healthcare in the second quarter valued at $164,000. Finally, Capstone Investment Advisors LLC purchased a new position in shares of Acadia Healthcare in the fourth quarter valued at $204,000.

Analyst Upgrades and Downgrades

ACHC has been the subject of several analyst reports. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research note on Monday, August 19th. Royal Bank of Canada restated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a research note on Friday. Barclays cut their price target on shares of Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating on the stock in a report on Thursday, August 1st. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. One analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, Acadia Healthcare currently has an average rating of “Moderate Buy” and an average target price of $87.44.

Acadia Healthcare Stock Down 0.3 %

Shares of NASDAQ:ACHC opened at $76.18 on Tuesday. The stock has a market capitalization of $7.07 billion, a price-to-earnings ratio of -544.14, a price-to-earnings-growth ratio of 2.22 and a beta of 1.30. Acadia Healthcare Company, Inc. has a 1-year low of $62.04 and a 1-year high of $87.77. The company’s fifty day moving average is $73.75 and its two-hundred day moving average is $71.83. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. The company had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The firm’s revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.92 earnings per share. Equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.